Menu

March Methods Madness

Thomson Reuters launches Metrics Mania, which will pit universities against each other, not on the basketball court, but in the scientific literature.

Mar 20, 2013
Bob Grant

Penn State vs. Colgate, circa 2007WIKIMEDIA, BEN STANFIELDAs the hoops action heats up in the world of college basketball, information company Thomson Reuters is rolling out its citation-based answer to March Madness. “Metrics Mania” will compare the institutional research productivity between the 64 colleges and universities from across the country that will square off starting tomorrow (March 21) in NCAA men’s basketball. Champions of both the basketball tournament and the research contest will be crowned on April 8. Using citation data derived from their Web of Knowledge, Thomson Reuters will provide regular updates concerning head-to-head matchups of the schools competing against each other on the court.

“We are very excited to host the first-ever Metrics Mania,” said Gordon Macomber, managing director of Scientific and Scholarly Research at Thomson Reuters, in a statement. “Not only will this be a fun program for the scholarly research community, but it will also give Thomson Reuters an opportunity to highlight the great research programs within the schools competing in our brackets.”

Bracket heads can follow along with the action at the Metrics Mania website, as well as on Twitter and Facebook.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.